FundedIQ
Biotechnology

Receptor Life Sciences: Funding, Investors & Team (Oct 2026)

Receptor Life Sciences is a biotechnology company

receptorlife.com Seattle, United States 1-10 employees
Total raised
$9.7M
Rounds
1
Latest
Series A
Apr 2022

Receptor Life Sciences has raised $9.7M across 1 funding round on record, the most recent a Series A of $9.7M announced in Apr 2022.

That round is above the $8.1M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Receptor Life Sciences Company Profile and Key Stats

Total funding raised
$9.7M
across 1 round on record
Funding rounds on record
1
Latest funding round
Series A
$9.7M in Apr 2022
Employees
1-10
reported band
Headquarters
Seattle, United States

Latest funding round on record: Apr 2022.

Receptor Life Sciences Funding Rounds

Date
Round
Amount
Series A
$9.7M

Receptor Life Sciences Founders and Leadership Team

Name
Role
Contact
Andrea Leone-Bay
Founder
—

No contact details are on record for this team yet.

Receptor Life Sciences Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,185
$8.1M
30,148
$7.5M
8,523
$15M

Receptor Life Sciences' latest round of $9.7M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Receptor Life Sciences in Biotechnology and Seattle

Companies Similar to Receptor Life Sciences

Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…

Undisclosed round $94.0M

Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…

Series B $9.5M

Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…

Series B $33.0M

Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…

Undisclosed round —

Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.

Series A $15.0M

Serán is a contract development and manufacturing organization providing a comprehensive suite of…

Private Equity —

Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…

Series D $250M

Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…

Series E $311M

Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…

Undisclosed round $8.5M

Circle Pharma is a biotechnology company in the initial stages of development that uses unique computational…

Series E $92.5M

Evvy is for people with vaginas who want to be empowered with information about their microbiome. Their…

Series B $40.0M

Datavant is a developer of a healthcare data platform dedicated to assisting in protecting, matching, and…

Private Equity —

Receptor Life Sciences Funding FAQs

What does Receptor Life Sciences do?

Receptor Life Sciences is a biotechnology company

How much funding has Receptor Life Sciences raised?

Receptor Life Sciences has raised $9.7M across 1 round on record. The most recent is a Series A of $9.7M announced in Apr 2022.

When did Receptor Life Sciences last raise funding?

Receptor Life Sciences' most recent funding round on record is a Series A of $9.7M, announced in Apr 2022.

Who founded Receptor Life Sciences?

FundedIQ lists Andrea Leone-Bay (Founder) at Receptor Life Sciences.

Where is Receptor Life Sciences headquartered?

Receptor Life Sciences is based in Seattle, Washington, United States.

How many employees does Receptor Life Sciences have?

Receptor Life Sciences is in the 1-10 employee band.

How does Receptor Life Sciences' funding compare to other Biotechnology startups?

Receptor Life Sciences' latest round of $9.7M is above the $8.1M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.

About FundedIQ's Receptor Life Sciences Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Receptor Life Sciences is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.

Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.